Shigellosis Caused by CTX-M Type ESBL Producing Shigella flexneri in Two Siblings of Rural Nepal: First Case Report from the Country

Abstract EN

Shigellosis is an acute infectious disease characterized as severe bloody diarrhea (dysentery) and is accountable for a significant burden of morbidity and mortality especially in children under the age of 5 years.

Antimicrobial therapy is required in the cases of severe dysentery associated with Shigella.

However, emergence of multidrug resistant (MDR) strains of Shigella spp.

over the last two decades has restricted the use of common therapeutic antimicrobials.

In MDR strains, the third-generation cephalosporins have been used for the treatment, but, unfortunately, emerging reports of enzyme mediated β-lactam resistance among Shigella isolates from various parts of the world have greatly compromised the therapy of pediatric dysentery.

In Nepal, drug resistant strains of Shigella spp.

have been reported, but MDR and extended spectrum β-lactamase (ESBL) producing strains were previously unknown.

Here, we report two Shigella flexneri isolates harboring ESBL genotype-CTX-M associated with acute dysentery in two siblings which were presented and treated in a tertiary care teaching hospital of Kathmandu, Nepal.